It was with astonishment that I read your editorial “Medicare’s Bad Call on Transplant Tests” (Sept. 11). The Centers for Medicare and Medicaid Services have made a poor decision to deny payment for innovative molecular tests to detect early signs of organ-transplant rejection. This vital testing…
#medicare #centersformedicare #medicaidservices #clinicians #cms
Continue reading...